Biofilm 101
Biofilm is one of the most studied, and least visible, problems in wound care. This guide explains what biofilm is, why it matters for hard-to-heal wounds, and how it connects to the global challenge of antimicrobial resistance, in plain language and with links to the research.
Why biofilm stalls wound healing
Healing normally moves through overlapping stages: stopping bleeding, inflammation, rebuilding tissue and remodeling. Biofilm can keep a wound stuck in the inflammatory stage. Reviews describe biofilm as promoting ongoing inflammation and protecting bacteria from the body's immune defenses, which makes it hard to clear with standard care. [5, 6]
Biofilm is common in wounds that won't heal. In a systematic review and meta-analysis of published human studies, biofilm was found in 78.2% of chronic wounds (nine studies, 185 wounds). [1]
Chronic wounds are a large and growing burden. They affect the quality of life of nearly 2.5% of the U.S. population [3], and a study of Medicare data found that nearly 15% of Medicare beneficiaries (8.2 million people) had at least one type of wound or wound-related infection in 2014. [4]
Why antibiotics struggle against biofilm
Antibiotics were largely developed and tested against free-floating bacteria. Inside a biofilm, bacteria are protected by "multicellular strategies" that differ from the classic genetic resistance of single cells. [2] Researchers describe several overlapping reasons:
- A physical shield. The matrix can slow or limit how far some antimicrobials penetrate. [6]
- Slow-growing and dormant cells. Many antibiotics target active growth. Some biofilm cells slow down or become dormant "persister" cells that can survive treatment and regrow afterward. [6]
- Protection from the immune system. The biofilm also shields bacteria from immune cells. [5]
How biofilm links to antimicrobial resistance (AMR)
Tolerance and resistance are related but different:
• Tolerance means bacteria survive a treatment without a genetic change, often because of the biofilm's protection and slow growth.
• Resistance means bacteria have acquired a genetic ability to defeat a drug, and they can pass that ability to other germs. [8]
Biofilms connect the two. When bacteria survive repeated or prolonged treatment, there are more opportunities for resistance to develop, and dense biofilm communities can share genetic material. A 2022 review in Nature Reviews Microbiology explores this role of biofilms in the development of resistance. [5, 6]
AMR is a major global health threat. The World Health Organization reports that bacterial AMR was associated with more than 4.7 million deaths worldwide in 2021, and that about 1 in 6 laboratory-confirmed bacterial infections were resistant to antibiotics in 2023. [9] In the United States, CDC estimates that more than 9.3 million drug-resistant infections occur each year and more than 39,000 people die as a result. [8] CDC lists drug-resistant germs such as MRSA and multidrug-resistant Pseudomonas aeruginosa among the threats, and notes that people with open wounds from surgery or burns are among those at higher risk for P. aeruginosa infection. [10, 11]
What researchers are exploring
Because biofilm is hard to remove with antibiotics alone, researchers are studying many different approaches. A 2025 review groups emerging research areas into categories such as: [12]
• Quorum-sensing inhibitors — compounds that interfere with how bacteria signal to each other.
• Bacteriophage therapy — viruses that infect specific bacteria.
• Matrix-disrupting enzymes — agents aimed at breaking down the biofilm's protective matrix.
• Electroceutical dressings — dressings that use electrical energy rather than drugs. A 2023 review groups these into ionic, wireless and battery-powered classes. [13]
• Antifungal strategies and nanotechnology-based materials.
Most of these approaches are still being studied. Today, standard wound care includes steps such as debridement (removing dead tissue and bioburden), managing infection and inflammation, and moisture control. [14] Conventional approaches like debridement and antiseptics reduce surface biofilm but rarely remove it completely, according to the 2025 review. [12]
Sources
Pavaka Wound Care is developing a powered wound dressing designed to target biofilm and drug-resistant pathogens. Investigational device; not FDA cleared or approved.
Educational information, not medical advice. This page is general educational content. It does not describe the use or performance of any Pavaka product. If you have a wound or infection, talk with a qualified healthcare professional.
1. Malone M, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26(1):20–25. https://pubmed.ncbi.nlm.nih.gov/28103163/
2. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135–138. https://pubmed.ncbi.nlm.nih.gov/11463434/
3. Sen CK. Human wound and its burden: updated 2020 compendium of estimates. Adv Wound Care. 2021;10(5):281–292. https://pubmed.ncbi.nlm.nih.gov/33733885/
4. Nussbaum SR, et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018;21(1):27–32. https://pubmed.ncbi.nlm.nih.gov/29304937/
5. Ciofu O, et al. Tolerance and resistance of microbial biofilms. Nat Rev Microbiol. 2022;20(10):621–635. https://pubmed.ncbi.nlm.nih.gov/35115704/
6. Goswami AG, et al. Biofilm and wound healing: from bench to bedside. Eur J Med Res. 2023;28:157. https://pmc.ncbi.nlm.nih.gov/articles/PMC10127443/
7. Rutherford ST, Bassler BL. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med. 2012;2(11):a012427. https://pubmed.ncbi.nlm.nih.gov/23125205/
8. CDC. About Antimicrobial Resistance (updated Oct 25, 2026). https://www.cdc.gov/antimicrobial-resistance/about/index.html — and CDC AR Threats Reports: https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html
9. WHO. Antimicrobial resistance fact sheet. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance — and WHO Global antibiotic resistance surveillance report 2025: https://www.who.int/publications/i/item/9789240116337
10. CDC. Methicillin-resistant Staphylococcus aureus (MRSA) Basics. https://www.cdc.gov/mrsa/about/index.html
11. CDC. About Pseudomonas aeruginosa. https://www.cdc.gov/pseudomonas-aeruginosa/about/index.html
12. Shen AZ, et al. Biofilms and chronic wounds: pathogenesis and treatment options. J Clin Med. 2025;14(21):7784. https://pubmed.ncbi.nlm.nih.gov/41227178/
13. Evans JP, Sen CK. Electrochemical devices in cutaneous wound healing. Bioengineering. 2023;10(6):711. https://pubmed.ncbi.nlm.nih.gov/37370642/
14. Manna B, et al. Wound Debridement. StatPearls (NCBI Bookshelf), 2023. https://pubmed.ncbi.nlm.nih.gov/29939659/

